These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

589 related articles for article (PubMed ID: 2522978)

  • 21. Evidence for a role in thrombus stabilization for thromboxane A2 in human platelet deposition on collagen.
    Wagner WR; Hubbell JA
    J Lab Clin Med; 1992 Jun; 119(6):690-7. PubMed ID: 1534345
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Platelet deposition induced by severely damaged vessel wall is inhibited by a boroarginine synthetic peptide with antithrombin activity.
    Badimon JJ; Weng D; Chesebro JH; Fuster V; Badimon L
    Thromb Haemost; 1994 Apr; 71(4):511-6. PubMed ID: 8052972
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Iloprost reduces procoagulant activity in the extracorporeal circuit.
    Korn RL; Fisher CA; Stenach N; Jeevanandam V; Addonizio VP
    J Surg Res; 1993 Oct; 55(4):433-40. PubMed ID: 7692141
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Inactivated factor VII exercises a powerful antithrombotic activity in an experimental model of recurrent arterial thrombosis].
    Ragni M; Golino P; Cirillo P; Pascucci I; Scognamiglio A; Ravera A; Esposito N; Battaglia C; Guarino A; Chiariello M
    Cardiologia; 1996 Jan; 41(1):51-8. PubMed ID: 8697470
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antithrombotic effects of combining activated protein C and urokinase in nonhuman primates.
    Gruber A; Harker LA; Hanson SR; Kelly AB; Griffin JH
    Circulation; 1991 Dec; 84(6):2454-62. PubMed ID: 1835678
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selective PF4 release in vitro induced by heparin and related glycosaminoglycans (GAGs)--correlation with beta-TG release and platelet aggregation.
    Cofrancesco E; Colombi M; Cristoforetti G; Pogliani EM
    Thromb Haemost; 1984 Feb; 51(1):105-7. PubMed ID: 6202020
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antithrombotic effects of thrombin-induced activation of endogenous protein C in primates.
    Hanson SR; Griffin JH; Harker LA; Kelly AB; Esmon CT; Gruber A
    J Clin Invest; 1993 Oct; 92(4):2003-12. PubMed ID: 8408654
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of factor VIII-von Willebrand factor and fibronectin in the interaction of platelets in flowing blood with monomeric and fibrillar human collagen types I and III.
    Houdijk WP; Sakariassen KS; Nievelstein PF; Sixma JJ
    J Clin Invest; 1985 Feb; 75(2):531-40. PubMed ID: 3919060
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Platelet compatibility of an artificial surface modified with functionally active heparin.
    Mollnes TE; Videm V; Christiansen D; Bergseth G; Riesenfeld J; Hovig T
    Thromb Haemost; 1999 Sep; 82(3):1132-6. PubMed ID: 10494777
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Studies of suloctidil in experimental thrombosis in baboons.
    Hanson SR; Harker LA
    Thromb Haemost; 1985 Jun; 53(3):423-7. PubMed ID: 2996168
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transient interruption of arterial thrombosis by inhibition of factor Xa results in long-term antithrombotic effects in baboons.
    Kotzé HF; Lamprecht S; Badenhorst PN; Roodt JP; van Wyk V
    Thromb Haemost; 1997 Jun; 77(6):1137-42. PubMed ID: 9241746
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selective inhibition by a synthetic hirudin peptide of fibrin-dependent thrombosis in baboons.
    Cadroy Y; Maraganore JM; Hanson SR; Harker LA
    Proc Natl Acad Sci U S A; 1991 Feb; 88(4):1177-81. PubMed ID: 1996320
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aspirin-independent antithrombotic effects of acutely attached cultured endothelial cells on endarterectomized arteries.
    Krupski WC; Bass A; Anderson JS; Kelly AB; Harker LA
    Surgery; 1990 Aug; 108(2):283-90; discussion 290-1. PubMed ID: 2382225
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dermatan sulfate inhibition of fibrin-rich thrombus formation in nonhuman primates.
    Cadroy Y; Hanson SR; Harker LA
    Arterioscler Thromb; 1993 Aug; 13(8):1213-7. PubMed ID: 8343496
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of heparin bonding on catheter-induced fibrin formation and platelet activation.
    Nichols AB; Owen J; Grossman BA; Marcella JJ; Fleisher LN; Lee MM
    Circulation; 1984 Nov; 70(5):843-50. PubMed ID: 6237807
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of collagen-adherent platelets in mediating fibrin formation in flowing whole blood.
    Kirchhofer D; Tschopp TB; Steiner B; Baumgartner HR
    Blood; 1995 Nov; 86(10):3815-22. PubMed ID: 7579349
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antithrombotic effects of synthetic peptides targeting various functional domains of thrombin.
    Kelly AB; Maraganore JM; Bourdon P; Hanson SR; Harker LA
    Proc Natl Acad Sci U S A; 1992 Jul; 89(13):6040-4. PubMed ID: 1385867
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Platelet function in sickle cell disease during steady state.
    Triadou P; Fonty E; Ambrosio AS; Cottat MC; Girot R; Cornu P
    Nouv Rev Fr Hematol (1978); 1990; 32(2):137-42. PubMed ID: 2143013
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Experimental arterial thromboembolism in baboons. Mechanism, quantitation, and pharmacologic prevention.
    Harker LA; Hanson SR
    J Clin Invest; 1979 Aug; 64(2):559-60. PubMed ID: 110835
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevention of heparin-resistant thrombotic occlusion of hollow-fiber hemodialyzers by synthetic antithrombin.
    Kelly AB; Hanson SR; Henderson LW; Harker LA
    J Lab Clin Med; 1989 Oct; 114(4):411-8. PubMed ID: 2794754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.